Pancreatic cancer microenvironment, to target or not to target?
We have collectively been spoiled by the astounding clinical benefit of antimicrobials. Much like the discovery and use of penicillin to eradicate once deadly infections, we continue to desperately search for the next “magic bullet” to kill cancer while sparing the non‐transformed cells. Greater appreciation for the molecular intricacies of malignancy has resulted in dedicated pursuit of cancer genomics and large‐scale informatics to identify “drugable” targets within the cancer cell itself. However, studies at the bench elucidating a dynamic relationship between tumor and microenvironment have become more common and demonstrate promise for novel therapeutic intervention.
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Pancreatic cancer microenvironment, to target or not to target? ; volume:8 ; number:2 ; year:2016 ; pages:80-82 ; extent:3
EMBO molecular medicine / European Molecular Biology Organization ; 8, Heft 2 (2016), 80-82 (gesamt 3)
- Urheber
-
Carr, Ryan M.
Fernandez‐Zapico, Martin E.
- DOI
-
10.15252/emmm.201505948
- URN
-
urn:nbn:de:101:1-2022111404592863735827
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:39 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Carr, Ryan M.
- Fernandez‐Zapico, Martin E.
Ähnliche Objekte (12)
Exosomes target HBV-host interactions to remodel the hepatic immune microenvironment
Multivalent γ‐PGA‐Exendin‐4 Conjugates to Target Pancreatic β‐Cells
Adaptive changes to saccade amplitude and target localization do not require pre-saccadic target visibility
Adaptive changes to saccade amplitude and target localization do not require pre-saccadic target visibility
Lipid metabolism in tumor microenvironment: novel therapeutic targets
To Target or Not to Target: Active vs. Passive Tumor Homing of Filamentous Nanoparticles Based on Potato virus X
Epigenetic Therapeutic Strategies to Target Molecular and Cellular Heterogeneity in Pancreatic Cancer
FMF is not always “fever”: from clinical presentation to “treat to target”
PCK1 as a target for cancer therapy: from metabolic reprogramming to immune microenvironment remodeling
Can no-lose targets contribute to a 2 °C target?
Epigenetic regulation and therapeutic targets in the tumor microenvironment
On Returning Inflation to Target
Exosomes target HBV-host interactions to remodel the hepatic immune microenvironment
Multivalent γ‐PGA‐Exendin‐4 Conjugates to Target Pancreatic β‐Cells
Adaptive changes to saccade amplitude and target localization do not require pre-saccadic target visibility
Adaptive changes to saccade amplitude and target localization do not require pre-saccadic target visibility
Lipid metabolism in tumor microenvironment: novel therapeutic targets
To Target or Not to Target: Active vs. Passive Tumor Homing of Filamentous Nanoparticles Based on Potato virus X
Epigenetic Therapeutic Strategies to Target Molecular and Cellular Heterogeneity in Pancreatic Cancer
FMF is not always “fever”: from clinical presentation to “treat to target”
PCK1 as a target for cancer therapy: from metabolic reprogramming to immune microenvironment remodeling
Can no-lose targets contribute to a 2 °C target?
Epigenetic regulation and therapeutic targets in the tumor microenvironment
On Returning Inflation to Target
Exosomes target HBV-host interactions to remodel the hepatic immune microenvironment
Multivalent γ‐PGA‐Exendin‐4 Conjugates to Target Pancreatic β‐Cells
Adaptive changes to saccade amplitude and target localization do not require pre-saccadic target visibility
Adaptive changes to saccade amplitude and target localization do not require pre-saccadic target visibility
Lipid metabolism in tumor microenvironment: novel therapeutic targets
To Target or Not to Target: Active vs. Passive Tumor Homing of Filamentous Nanoparticles Based on Potato virus X
Epigenetic Therapeutic Strategies to Target Molecular and Cellular Heterogeneity in Pancreatic Cancer
FMF is not always “fever”: from clinical presentation to “treat to target”
PCK1 as a target for cancer therapy: from metabolic reprogramming to immune microenvironment remodeling
Can no-lose targets contribute to a 2 °C target?
Epigenetic regulation and therapeutic targets in the tumor microenvironment